SKLB-163
目录号 : KE7616
CAS No. : 1255099-06-9
纯度 : ≥95%
SKLB-163 acts by downregulating RhoGDI, activating JNK-1 signaling pathway and caspase-3, and reducing phosphorylated Akt and p44/42 MAPK.
Other Forms of Rapamycin:
KKL Med 的所有产品和服务仅用于科学研究,不能被用于人体,兽医,我们也不向个人提供产品和服务。
KKL 顾客使用本产品发表的 0 篇科研文献
暂无科研文献
| 生物活性 |
SKLB-163 acts by downregulating RhoGDI, activating JNK-1 signaling pathway and caspase-3, and reducing phosphorylated Akt and p44/42 MAPK.
|
| 分子式 |
C18H16ClN3O2S2
|
| 分子量 |
405.91
|
| CAS号 |
1255099-06-9
|
| 中文名称 |
N-苄基-2-[6-(2-氯乙酰氨基)-苯并噻唑-2-基硫烷基]-乙酰胺
|
| 运输条件 |
Room temperature in continental US; may vary elsewhere.
|
| 储存方式 |
| Powder |
-20°C |
3 years |
| |
4°C |
2 years |
| In solvent |
-80°C |
6 months |
| |
-20°C |
1 month |
|